Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1, indicating a new release. The 'Back to Top' element was removed as a minor UI change; no other core content changes are detected.
    Difference
    0.1%
    Check dated 2025-09-14T18:50:00.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T13:17:40.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations across various countries, while also removing several previously listed locations. Notably, the content related to drug safety and counterfeit drugs has been expanded.
    Difference
    19%
    Check dated 2025-08-31T11:12:46.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T00:54:56.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T19:58:09.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed information about a new clinical trial for Rilzabrutinib, including study design, eligibility criteria, and locations for participation. This trial focuses on treating Chronic Spontaneous Urticaria (CSU) and provides comprehensive data on the study's phases and outcomes.
    Difference
    100%
    Check dated 2025-08-02T14:39:24.000Z thumbnail image

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.